C. Fernandez-patron et al., Differential regulation of platelet aggregation by matrix metalloproteinases-9 and-2, THROMB HAEM, 82(6), 1999, pp. 1730-1735
We have recently found matrix metalloproteinase-2 (MMP-2) in human platelet
s and reported that the release of this enzyme during platelet activation s
timulates aggregation. We have now identified matrix metalloproteinase-9 (M
MP-9) in human platelets and resistance-sized (similar to 200 mu m) arterie
s. Resting platelets released small quantities of pro-MMP-9. Maximal releas
e of MMP-9 was detected during partial (appr. 30% maximum) aggregation with
thrombin, However, maximal release of MMP-2 was associated with maximal ag
gregation. MMP-9 antibodies induced aggregation of resting platelets and po
tentiated aggregation of platelets induced by thrombin and collagen. Moreov
er, MMP-9 microisolated from arteries as well as recombinant human MMP-9 (0
.1-30 ng/ml) inhibited thrombin and collagen-induced aggregation. We conclu
de that MMP-9 is an inhibitor of aggregation and in this action opposes the
effects of MMP-2 The MMP-2/MMP-9 system may play an important role in the
regulation of platelet-platelet and platelet-vessel wall interactions.